Washington: The United States said it was ready to ship its COVID19 vaccine quickly after the Indian government approved it. The Indian government told Americans that it needed more time to review the legal requirements related to receiving vaccine donations.
State Department spokesperson Ned Price told reporters at a daily press conference: “When we get approval from the Indian government, we are ready to ship these vaccines quickly.”
The Biden administration announced that it will share its domestic inventory of 80 million doses with countries around the world, including India. In recent weeks, US vaccines have reached countries around the world, including Pakistan, Nepal, Bhutan and Bangladesh.
However, because the Indian government has not overcome the legal barriers required for such emergency imports, the vaccine cannot be shipped to India.
“However, before shipping these doses, each country must complete its own set of national operations, oversight and legal procedures for each country. Now, India has determined that it needs more time to review and accept the relevant legal requirements. Donation of vaccines, “Price said.
“Once India approves its legal process, we will quickly donate vaccines to India. We need to refer it to the Indian government to understand their discussions with COVAX, in this case this helps facilitate that delivery,” he says.
“More generally, across South Asia, we are donating millions of vaccine doses to Afghanistan, Bangladesh, Bhutan, Nepal, Maldives, Pakistan, and Sri Lanka. Approximately 40 million vaccine doses have been delivered to date. all over the world, “he added.
Responding to another question, Price said that the COVID19 cooperation between the two countries builds on decades of successful cooperation in health and biomedical research.
He said: “We are collaborating to strengthen the global response to COVID19, address infectious disease outbreaks, strengthen health systems and protect global supply chains.”
“We recently welcomed initiatives to collaborate through the International Center for Research of Excellence, with a focus on infectious diseases, in this case including COVID19 and other emerging threats. We look forward to a general memorandum of understanding, a memorandum of understanding to strengthen cooperation beyond health, “he added.
The two countries are working harder to research diagnosis, treatment and vaccines to combat this disease, and recognize the importance of manufacturing key drugs during this period and making them globally accessible.
“We can do this because the Indian pharmaceutical industry is strong and mature, and has played a central role in manufacturing vaccines for global use over a period of time. We are very pleased that US pharmaceutical companies in turn coordinated with their Indian counterparts because of the pandemic Start,” Price said.
“As you know, in addition to this partnership, in the context of the summit of leaders of the four countries, the two sides reached an agreement to cooperate with India to promote the production of Covid vaccines to support the safe and effective vaccines worldwide And finally distributed universally.,” he said.